Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
Universidad Francisco de Vitoria · Research Institute Hospital 12 de Octubre · +4 more institutions
Abstract
Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), is a heterogeneous state of chronic intestinal inflammation with no exact known cause. Intestinal innate immunity is enacted by neutrophils, monocytes, macrophages, and dendritic cells (DCs), and innate lymphoid cells and NK cells, characterized by their capacity to produce a rapid and nonspecific reaction as a first-line response. Innate immune cells (IIC) defend against pathogens and excessive entry of intestinal microorganisms, while preserving immune tolerance to resident intestinal microbiota. Changes to this equilibrium are linked to intestinal inflammation in the gut and IBD. IICs mediate host defense…
Citation impact
- FWCI
- 77.94
- Percentile
- 100%
- References
- 279
Authors
5- ÁSÁngela Saéz
Universidad Francisco de Vitoria, Research Institute Hospital 12 de Octubre
- BHBeatriz Herrero‐Fernández
Research Institute Hospital 12 de Octubre, Universidad Autónoma de Madrid
- RGRaquel Gómez-Bris
Research Institute Hospital 12 de Octubre, Universidad Autónoma de Madrid
- HSHector Sánchez-Martinez
Research Institute Hospital 12 de Octubre
- JMJosé María GonzálezCorresponding
Universidad Complutense de Madrid, Spanish National Centre for Cardiovascular Research, Research Institute Hospital 12 de Octubre, Centro de Investigación en Red en Enfermedades Cardiovasculares
Topics & keywords
- Innate immune system
- Immune system
- Immunology
- Innate lymphoid cell
- CCL18
- Inflammation
- Acquired immune system
- Inflammatory bowel disease
Funding
- CDComunidad de MadridAwards: FPU19/01774, PEJ-2020-TL/BMD-17604, FPU18/00895, PI20/00306
- UFUniversidad Francisco de Vitoria
- MDMinisterio de Ciencia, Innovación y UniversidadesAwards: FPU18/00895, FPU19, FPU19/01774
- CNCentro Nacional de Investigaciones Cardiovasculares
- SServier
- IDInstituto de Salud Carlos IIIAwards: PI20/00306, FPU18/00895, PEJ-2020-TL/BMD-17604, FPU19/01774
- EREuropean Regional Development Fund